Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,008B 10.47B 9.15B 8.44B 7.78B 14.67B 14.99B 101B 39.69B 494B 39.32B 38.46B 1,700B P/E 2027 *
24x
P/E 2028 * 19.3x
Enterprise Value 976B 10.13B 8.85B 8.17B 7.53B 14.19B 14.51B 97.65B 38.41B 478B 38.05B 37.21B 1,645B EV / Sales 2027 *
2.74x
EV / Sales 2028 * 2.42x
Free-Float
70.07%
Yield 2027 *
0.64%
Yield 2028 * 0.69%

Last Transcript: Dr. Reddy's Laboratories Limited

1 day-1.07%
1 week-2.78%
Current month-10.76%
1 month-4.49%
3 months-1.99%
6 months+3.00%
Current year-4.74%
1 week 1,203
Extreme 1203
1,255.85
1 month 1,203
Extreme 1203
1,414.4
Current year 1,149
Extreme 1149
1,414.4
1 year 1,149
Extreme 1149
1,414.4
3 years 1,025.9
Extreme 1025.9
1,420.2
5 years 731
Extreme 731
1,420.2
10 years 377.6
Extreme 377.6
1,420.2
Manager TitleAgeSince
Chief Executive Officer 59 30/06/2019
Director of Finance/CFO - 31/07/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 12/05/2014
Chairman 65 01/04/2013
Director/Board Member 65 24/10/2018
Date Insider Type Main position Quantity % Market Cap.
01/04/26 Other

Global Head of Quality and PV

35,600 0.0043%
18/12/25 Other

GLOBAL HEAD - IPDO

70 0.0000%
18/12/25 Other

Executive/Senior Manager

8,450 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-1.07%-2.78%-3.76%+16.63% 10.47B
+0.85%-0.80%+52.79%+161.33% 1,051B
+1.23%-1.53%+54.58%+59.08% 609B
+0.04%+2.58%+34.47%+86.33% 450B
+0.78%-0.71%+29.28%+24.10% 330B
+1.41%+0.58%+35.44%+40.67% 284B
-0.27%-1.87%+22.34%+22.51% 263B
-1.76%+2.37%-20.43%-38.00% 223B
-1.42%+0.80%+24.27%+57.50% 198B
-1.48%+3.43%+24.08%+71.67% 167B
Average -0.17%+0.21%+25.31%+50.18% 358.55B
Weighted average by Cap. +0.37%+0.02%+37.39%+79.45%

Financials

2027 *2028 *
Net sales 356B 3.7B 3.23B 2.98B 2.75B 5.18B 5.3B 35.64B 14.02B 174B 13.89B 13.58B 600B 395B 4.1B 3.58B 3.31B 3.05B 5.75B 5.87B 39.54B 15.55B 193B 15.4B 15.07B 666B
Net income 42.32B 439M 384M 354M 327M 616M 629M 4.24B 1.67B 20.73B 1.65B 1.61B 71.35B 52.91B 549M 480M 443M 408M 770M 787M 5.3B 2.08B 25.91B 2.06B 2.02B 89.2B
Net Debt -32.67B -339M -296M -274M -252M -475M -486M -3.27B -1.29B -16B -1.27B -1.25B -55.08B -54.24B -563M -492M -454M -419M -789M -807M -5.43B -2.14B -26.56B -2.12B -2.07B -91.45B
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
17/07/26 ₹1,210.85 -1.07% 87,318
16/07/26 ₹1,223.90 -0.48% 93,465
15/07/26 ₹1,229.80 -1.28% 69,828
14/07/26 ₹1,245.75 +0.90% 90,099
13/07/26 ₹1,234.60 -0.88% 141,261
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
40
Last Close Price
1,210.85INR
Average target price
1,336.30INR
Spread / Average Target
+10.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DRREDDY Stock